ArtVentive Medical Group, Inc.: 10-Q filed 2012-04-30
What ArtVentive Medical Group, Inc. reported in its quarterly report filed 2012-04-30 (fiscal Q1 2012): 16 published measures, 37 facts as tagged in accession 0001056520-12-000179.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-04-30
- Fiscal period
- fiscal Q1 2012
- Accession
- 0001056520-12-000179 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ArtVentive Medical Group, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 44,489 | USD | |
| At 2011-12-31 | 101,193 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | -439,703 | USD | |
| At 2011-12-31 | -273,257 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -56,635 | USD | 91 |
| 2007-01-23 to 2012-03-31 | -3,392,614 | USD | 1895 |
| 2011-01-01 to 2011-03-31 | -432,786 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2007-01-23 to 2012-03-31 | 3,436,080 | USD | 1895 |
| 2011-01-01 to 2011-03-31 | 500,000 | USD | 90 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2007-01-23 to 2012-03-31 | -1,880 | USD | 1895 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 49,156,941 | shares | 91 |
| 2011-01-01 to 2011-03-31 | 46,814,117 | shares | 90 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 807 | USD | |
| At 2011-12-31 | 876 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -166,453 | USD | 91 |
| 2007-01-23 to 2012-03-31 | -4,058,393 | USD | 1895 |
| 2011-01-01 to 2011-03-31 | -435,685 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 42,634 | USD | |
| At 2011-12-31 | 99,269 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 484,192 | USD | |
| At 2011-12-31 | 374,450 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 73,714 | USD | 91 |
| 2007-01-23 to 2012-03-31 | 1,179,707 | USD | 1895 |
| 2011-01-01 to 2011-03-31 | 80,072 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 92,670 | USD | 91 |
| 2007-01-23 to 2012-03-31 | 2,832,062 | USD | 1895 |
| 2011-01-01 to 2011-03-31 | 355,544 | USD | 90 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 3,565,403 | USD | |
| At 2011-12-31 | 3,565,403 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | -575 | USD | |
| At 2011-12-31 | -506 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -166,446 | USD | 91 |
| 2007-01-23 to 2012-03-31 | -4,054,355 | USD | 1895 |
| 2011-01-01 to 2011-03-31 | -435,557 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 79,199 | USD | 91 |
| 2007-01-23 to 2012-03-31 | 453,628 | USD | 1895 |
| 2011-01-01 to 2011-03-31 | -5,395 | USD | 90 |
Inspect the source
- Entity
- ArtVentive Medical Group, Inc. / CIK 0001405249
- Captured
- SEC response SHA-256
01b8937f2876d513617b1d921d4a98ec6f536680d197470785bad286f4947f07
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001405249.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))